Morphometricity as a measure of the neuroanatomical signature of a trait

Complex physiological and behavioral traits, including neurological and psychiatric disorders, often associate with distributed anatomical variation. This paper introduces a global metric, called morphometricity, as a measure of the anatomical signature of different traits. Morphometricity is defined as the proportion of phenotypic variation that can be explained by macroscopic brain morphology. We estimate morphometricity via a linear mixed-effects model that uses an anatomical similarity matrix computed based on measurements derived from structural brain MRI scans. We examined over 3,800 unique MRI scans from nine large-scale studies to estimate the morphometricity of a range of phenotypes, including clinical diagnoses such as Alzheimer’s disease, and nonclinical traits such as measures of cognition. Our results demonstrate that morphometricity can provide novel insights about the neuroanatomical correlates of a diverse set of traits, revealing associations that might not be detectable through traditional statistical techniques.National Institute for Biomedical Imaging and Bioengineering (U.S.) (R01EB006758)National Institute for Biomedical Imaging and Bioengineering (U.S.) (P41EB015896)National Institute for Biomedical Imaging and Bioengineering (U.S.) (R21EB018907)National Institute for Biomedical Imaging and Bioengineering (U.S.) (R01EB019956)National Institute on Aging (5R01AG008122)National Institute on Aging (R01AG016495)National Institute of Neurological Diseases and Stroke (U.S.) (R01NS0525851)National Institute of Neurological Diseases and Stroke (U.S.) (R21NS072652)National Institute of Neurological Diseases and Stroke (U.S.) (R01NS070963)National Institute of Neurological Diseases and Stroke (U.S.) (R01NS083534)National Institute of Neurological Diseases and Stroke (U.S.) (5U01NS086625)United States. National Institutes of Health (5U01-MH093765)United States. National Institutes of Health (R01NS083534)United States. National Institutes of Health (R01NS070963)United States. National Institutes of Health (R41AG052246)United States. National Institutes of Health (1K25EB013649-01

Longitudinal thalamic white and gray matter changes associated with visual hallucinations in Parkinson’s disease

Objective: Visual hallucinations are common in Parkinson’s disease (PD) and associated with worse outcomes. Large-scale network imbalance is seen in PD-associated hallucinations, but mechanisms remain unclear. As the thalamus is critical in controlling cortical networks, structural thalamic changes could underlie network dysfunction in PD hallucinations. Methods: We used whole-brain fixel-based analysis and cortical thickness measures to examine longitudinal white and grey matter changes in 76 patients with PD (15 hallucinators, 61 non-hallucinators) and 26 controls at baseline, and after 18 months. We compared white matter and cortical thickness, adjusting for age, gender, time-between-scans and intracranial volume. To assess thalamic changes, we extracted volumes for 50 thalamic subnuclei (25 each hemisphere) and mean fibre crosssection (FC) for white matter tracts originating in each subnucleus and examined longitudinal change in PDhallucinators versus non-hallucinators. Results: PD hallucinators showed white matter changes within the corpus callosum at baseline and extensive posterior tract involvement over time. Less extensive cortical thickness changes were only seen after followup. White matter connections from the right medial mediodorsal magnocellular thalamic nucleus showed reduced FC in PD hallucinators at baseline followed by volume reductions longitudinally. After follow-up, almost all thalamic subnuclei showed tract losses in PD hallucinators compared with non-hallucinators. Interpretation: PD hallucinators show white matter loss particularly in posterior connections and in thalamic nuclei, over time with relatively preserved cortical thickness. The right medial mediodorsal thalamic nucleus shows both connectivity and volume loss in PD hallucinations. Our findings provide mechanistic insights into the drivers of network imbalance in PD hallucinations and potential therapeutic targets

Fast and accurate modelling of longitudinal and repeated measures neuroimaging data

Despite the growing importance of longitudinal data in neuroimaging, the standard analysis methods make restrictive or unrealistic assumptions (e.g., assumption of Compound Symmetry—the state of all equal variances and equal correlations—or spatially homogeneous longitudinal correlations). While some new methods have been proposed to more accurately account for such data, these methods are based on iterative algorithms that are slow and failure-prone. In this article, we propose the use of the Sandwich Estimator (SwE) method which first estimates the parameters of interest with a simple Ordinary Least Square model and second estimates variances/covariances with the “so-called” SwE which accounts for the within-subject correlation existing in longitudinal data. Here, we introduce the SwE method in its classic form, and we review and propose several adjustments to improve its behaviour, specifically in small samples. We use intensive Monte Carlo simulations to compare all considered adjustments and isolate the best combination for neuroimaging data. We also compare the SwE method to other popular methods and demonstrate its strengths and weaknesses. Finally, we analyse a highly unbalanced longitudinal dataset from the Alzheimer's Disease Neuroimaging Initiative and demonstrate the flexibility of the SwE method to fit within- and between-subject effects in a single model. Software implementing this SwE method has been made freely available at http://warwick.ac.uk/tenichols/SwE

Social isolation is linked to declining grey matter structure and cognitive functions in the LIFE-Adult panel study

Social isolation has been suggested to increase the risk to develop cognitive decline. However, our knowledge on causality and neurobiological underpinnings is still limited. In this preregistered analysis, we tested the impact of social isolation on central features of brain and cognitive aging using a longitudinal population-based magnetic resonance imaging (MRI) study. Assaying 1335 cognitively healthy participants (50-80 years old, 659 women) at baseline and 895 participants after ∼6 years follow-up, we found baseline social isolation and change in social isolation to be associated with smaller volumes of the hippocampus, reduced cortical thickness and poorer cognitive functions. Combining advanced neuroimaging outcomes with prevalent lifestyle characteristics from a well-characterized population of middle- to older aged adults, we provide evidence that social isolation contributes to human brain atrophy and cognitive decline. Within-subject effects of social isolation were similar to between-subject effects, indicating an opportunity to reduce dementia risk by promoting social networks

Moderating Effect of Cortical Thickness on BOLD Signal Variability Age-Related Changes

The time course of neuroanatomical structural and functional measures across the lifespan is commonly reported in association with aging. Blood oxygen-level dependent signal variability, estimated using the standard deviation of the signal, or “BOLDSD,” is an emerging metric of variability in neural processing, and has been shown to be positively correlated with cognitive flexibility. Generally, BOLDSD is reported to decrease with aging, and is thought to reflect age-related cognitive decline. Additionally, it is well established that normative aging is associated with structural changes in brain regions, and that these predict functional decline in various cognitive domains. Nevertheless, the interaction between alterations in cortical morphology and BOLDSD changes has not been modeled quantitatively. The objective of the current study was to investigate the influence of cortical morphology metrics [i.e., cortical thickness (CT), gray matter (GM) volume, and cortical area (CA)] on age-related BOLDSD changes by treating these cortical morphology metrics as possible physiological confounds using linear mixed models. We studied these metrics in 28 healthy older subjects scanned twice at approximately 2.5 years interval. Results show that BOLDSD is confounded by cortical morphology metrics. Respectively, changes in CT but not GM volume nor CA, show a significant interaction with BOLDSD alterations. Our study highlights that CT changes should be considered when evaluating BOLDSD alternations in the lifespan

Instantiated mixed effects modeling of Alzheimer's disease markers

The assessment and prediction of a subject's current and future risk of developing neurodegenerative diseases like Alzheimer's disease are of great interest in both the design of clinical trials as well as in clinical decision making. Exploring the longitudinal trajectory of markers related to neurodegeneration is an important task when selecting subjects for treatment in trials and the clinic, in the evaluation of early disease indicators and the monitoring of disease progression. Given that there is substantial intersubject variability, models that attempt to describe marker trajectories for a whole population will likely lack specificity for the representation of individual patients. Therefore, we argue here that individualized models provide a more accurate alternative that can be used for tasks such as population stratification and a subject-specific prognosis. In the work presented here, mixed effects modeling is used to derive global and individual marker trajectories for a training population. Test subject (new patient) specific models are then instantiated using a stratified “marker signature” that defines a subpopulation of similar cases within the training database. From this subpopulation, personalized models of the expected trajectory of several markers are subsequently estimated for unseen patients. These patient specific models of markers are shown to provide better predictions of time-to-conversion to Alzheimer's disease than population based models

Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis

Individuals face discrimination based on characteristics including race/ethnicity, gender, age, and disability. Discriminatory experiences (DE) are associated with poor psychological health in the general population and with worse outcomes among individuals at clinical high risk for psychosis (CHR). Though the brain is sensitive to stress, and brain structural change is a well-documented precursor to psychosis, potential relationships between DE and brain structure among CHR or healthy individuals are not known. This report assessed whether lifetime DE are associated with cortical thinning and clinical outcomes across time, after controlling for discrimination-related demographic factors among CHR individuals who ultimately do (N = 57) and do not convert to psychosis (N = 451), and healthy comparison (N = 208) participants in the North American Prodrome Longitudinal Study 2. Results indicate that DE are associated with thinner cortex across time in several cortical areas. Thickness in several right hemisphere regions partially mediates associations between DE and subsequent anxiety symptoms, but not attenuated positive symptoms of psychosis. This report provides the first evidence to date of an association between DE and brain structure in both CHR and healthy comparison individuals. Results also suggest that thinner cortex across time in areas linked with DE may partially explain associations between DE and cross-diagnostic indicators of psychological distress

Structure-Function Relationships in the Brain: Applications in Neurosurgery

Multimodal brain imaging allows the study of structure-function relationships of the brain at the individual level, a key subject in basic neuroscience with important applications in neurosurgery. The current thesis aims to better understand these relationships by (1) examining how cortical morphology metrics influence measures of brain function, (2) their visualization in augmented reality (AR), and (3) their application in neurosurgical planning. To achieve these objectives, we made use of multimodal magnetic resonance imaging (MRI) data: diffusion weighted imaging, resting-state functional MRI (rs-fMRI), task-based fMRI, and T1-weighted images. Various metrics were calculated: cortical thickness (CT), blood oxygen level dependent signal variability (BOLDSD), structural connectivity (SC), functional connectivity (FC), etc.. We found that BOLDSD measures are confounded by CT, developed an application to visualize SC and FC in AR, and used rs-fMRI to map language for epilepsy surgery. Overall, these studies provided a better understanding of structure-function relationships in the brain

Imaging biomarkers extraction and classification for Prion disease

Prion diseases are a group of rare neurodegenerative conditions characterised by a high rate of progression and highly heterogeneous phenotypes. Whilst the most common form of prion disease occurs sporadically (sporadic Creutzfeldt-Jakob disease, sCJD), other forms are caused by inheritance of prion protein gene mutations or exposure to prions. To date, there are no accurate imaging biomarkers that can be used to predict the future diagnosis of a subject or to quantify the progression of symptoms over time. Besides, CJD is commonly mistaken for other forms of dementia. Due to the large heterogeneity of phenotypes of prion disease and the lack of a consistent spatial pattern of disease progression, the approaches used to study other types of neurodegenerative diseases are not satisfactory to capture the progression of the human form of prion disease. Using a tailored framework, I extracted quantitative imaging biomarkers for characterisation of patients with Prion diseases. Following the extraction of patient-specific imaging biomarkers from multiple images, I implemented a Gaussian Process approach to correlated symptoms with disease types and stages. The model was used on three different tasks: diagnosis, differential diagnosis and stratification, addressing an unmet need to automatically identify patients with or at risk of developing Prion disease. The work presented in this thesis has been extensively validated in a unique Prion disease cohort, comprising both the inherited and sporadic forms of the disease. The model has shown to be effective in the prediction of this illness. Furthermore, this approach may have used in other disorders with heterogeneous imaging features, being an added value for the understanding of neurodegenerative diseases. Lastly, given the rarity of this disease, I also addressed the issue of missing data and the limitations raised by it. Overall, this work presents progress towards modelling of Prion diseases and which computational methodologies are potentially suitable for its characterisation